Sławomir Jeka

4.5k citations
98 papers · 2.2k indexed · 2 hit papers · h-index 22

Sławomir Jeka

88 papers receiving 2.1k citations

Hit Papers

Trial of Upadacitinib and Adalim...1822013202620172021100200300400

Peers

Sławomir Jeka
Comparison fields: 5 of 96
  • Rheumatology 1.1k
  • Immunology 1.1k
  • Hematology 409
  • Genetics 154
  • Endocrine and Autonomic Systems 97
Replace Alessandra Bortoluzzi with:
Alessandra Bortoluzzi Italy
Liangjing Lu China
Maureen Rischmueller Australia
Jin Sun Lee South Korea
Won Park South Korea
Maria Eveslage Germany
Yohei Kirino Japan
Nemanja Damjanov Serbia
Serge Steinfeld Belgium
Renee Perdok United States
Sławomir Jeka relative to Alessandra Bortoluzzi Italy Alessandra Bortoluzzi's profile →
Citations per field
00.5×10.8×
Alessandra Bortoluzzi · 1×
Citations per year

Countries citing papers authored by Sławomir Jeka

Since Specialization
Citations

This map shows the geographic impact of Sławomir Jeka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sławomir Jeka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sławomir Jeka more than expected).

Fields of papers citing papers by Sławomir Jeka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sławomir Jeka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sławomir Jeka. The network helps show where Sławomir Jeka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sławomir Jeka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sławomir Jeka Line = papers co-authored together Sławomir Jeka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 20246
4 202320
5 202110
6 2020110
7 202085
8 201927
9 20189
10 20186
11
Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re-Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized, Double-Blind Study
20172
12
Biopodobne leki biologiczne w reumatologii
20171
13 20170
14 201621
15 201515
16 20150
17
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
201318
18 201325
19
Osteolytic lesions in the pelvis of the patient with an aggressive form of psoriatic arthritis
20120
20
Ultrasonography of synovium in rheumatological diseases
20102

About Sławomir Jeka

Sławomir Jeka is a scholar working on Rheumatology, Immunology and Hematology, having authored 98 papers that have together received 2.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (41 papers), Spondyloarthritis Studies and Treatments (19 papers), Biosimilars and Bioanalytical Methods (18 papers), Systemic Lupus Erythematosus Research (16 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Pharmaceutical studies and practices (8 papers). The work is most often cited by research in Rheumatology (1.1k citations), Immunology (1.1k citations) and Hematology (409 citations). Sławomir Jeka has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Stanisław Sierakowski, Klaus Krueger, Frank Buttgereit, Erika Gromnica‐Ihle, Jacek Szechiński, Sang Joon Lee, Paweł Hrycaj, Volodymyr Kovalenko, Dae‐Hyun Yoo and Mie Jin Lim. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026